Wave 80 Receives SBIR Grant to Develop No-spin Sample Prep for Chlamydia MDx | GenomeWeb

Molecular diagnostic company Wave 80 Biosciences has received Phase I Small Business Innovation Research funding from the National Institutes of Health to develop rapid sample prep to support chlamydia testing in low-resource settings.

The two-year grant, administered by the National Institute of Allergy and Infectious Diseases, provides $300,000 in the first year to develop solid phase RNA extraction, filtering, lysis, and binding to a porous polymer monolith, in order to extract nucleic acids from vaginal swabs or urine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.